Review Anti-infectives: Tuberculosis: Current status and recent developments in diagnostics, drugs and vaccines
- 29 February 1996
- journal article
- Published by Informa Healthcare in Expert Opinion on Therapeutic Patents
- Vol. 6 (2) , 175-185
- https://doi.org/10.1517/13543776.6.2.175
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- The global tuberculosis situation and the new control strategy of the World Health OrganizationPublished by Elsevier ,2004
- Prospects for new vaccines against tuberculosisTrends in Microbiology, 1995
- The Presence of β-D-Ribosyl-1-monophosphodecaprenol in MycobacteriaPublished by Elsevier ,1995
- Current and Potential Treatment of TuberculosisDrugs, 1994
- Multiple-Drug-Resistant TuberculosisClinical Infectious Diseases, 1994
- The New TuberculosisNew England Journal of Medicine, 1992
- Is Africa lost?The Lancet, 1991
- Immunotherapy with Mycobacterium vaccae as an adjunct to chemotherapy in the treatment of pulmonary tuberculosisTubercle, 1990
- A Prospective Study of the Risk of Tuberculosis among Intravenous Drug Users with Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1989
- In-vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium kansasii to amoxycillin and ticarcillin in combination with clavulanic acidJournal of Antimicrobial Chemotherapy, 1988